CrushSCI.com
提供学术论文选刊润色服务
CANCER CHEMOTHERAPY AND PHARMACOLOGY 期刊封面 医学
返回期刊列表

Review Cycle Records

CANCER CHEMOTHERAPY AND PHARMACOLOGY

Springer SCIE 非OA
2026新锐 4区2025中科院 4区2025 JCR Q3
101.8平均天数
105中位天数
42最短天数
152最长天数
1122025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

124 天

Pharmacokinetic comparison of cisplatin administration via HIPEC and intravenous infusion in a porcine model

作者Christina Harlev; Elisabeth Krogsgaard Petersen; Mats Bue; Lone Kjeld Petersen; Johanne Gade Lilleøre; Anne Vibeke Schmedes; Bo Martin Bibby; Maiken Stilling

作者单位1. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; 2. Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark; 3. Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark; 4. Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark; 5. Department of Clinical Research, University of Southern Denmark, Odense, Denmark; 6. Department of Biochemistry and Immunology, Lillebaelt Hospital, University Hospital of Southern, Vejle, Denmark; 7. Department of Biostatistics, Aarhus University, Aarhus, Denmark

PDF源文件 DOI 网页
42 天

Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy

作者Matthieu Gracia; Sabrina Marsili; Julien Vintejoux; Laurence Gladieff; Etienne Chatelut; Fabienne Thomas

作者单位1. Univ Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Inserm, CRCT, Toulouse, France; 2. Univ Toulouse, Oncopole Claudius-Regaud, IUCT-Oncopole, Toulouse, France

PDF源文件 DOI 网页
103 天

Lack of effects of S -equol-containing supplement on the pharmacokinetics of oral hormone therapy drugs for breast cancer

作者Takehiko Sambe; Chiyo K. Imamura; Noriko Hida; Taigi Yamazaki; Takuya Mizukami; Kakei Ryu; Koya Fukunaga; Taisei Mushiroda; Haruna Miyakawa; Shigeto Uchiyama; Naoki Uchida; Shinichi Kobayashi

作者单位1. Division of Clinical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; 2. Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; 3. Advanced Cancer Translational Research Institute, Showa Medical University, Tokyo, Japan; 4. Division of Clinical Research and Development, Department of Clinical Pharmacy, Showa Medical University School of Pharmacy, Tokyo, Japan; 5. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; 6. Nutraceuticals Research Institute, Otsuka Pharmaceutical Co., Ltd., Saga, Japan

PDF源文件 DOI 网页
120 天

Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib)

作者Lin Fang; Xin Jiang; Kexiu Song; Ping Shi; Li Wang; Lingmei Xu; Xianghui Duan; Fei Liu; Feifei Sun; Rongxin Ban; Yaping Ma; Chenjing Wang; Yu Cao

作者单位1. Phase I Clinical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, China; 2. Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, China; 3. Clinical Medicine Department, XuanZhu Biopharm Co., Ltd, Shijiazhuang, China; 4. Clinical Pharmacology Department, XuanZhu Biopharm Co., Ltd, Shijiazhuang, China; 5. Biostatistics Department, XuanZhu Biopharm Co., Ltd, Shijiazhuang, China

PDF源文件 DOI 网页
48 天

Association of DPYD rs4294451, plasma uracil concentration, and sex with 5-fluorouracil exposure in patients with gastrointestinal cancer

作者Gabriel A. Brooks; Dylan B. Ness; Kathryn C. Hourdequin; Gregory H. Ripple; Manik Amin; Sierra Lord-Halvorson; Wahab A. Khan; Sophie J. Deharvengt; Vincent Busque; Konstantin H. Dragnev; Wenyan Zhao; Tor D. Tosteson; Lionel D. Lewis

作者单位1. Dartmouth Cancer Center, Lebanon, USA; 2. Geisel School of Medicine, Lebanon, USA; 3. Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, USA; 4. University of Chicago Comprehensive Cancer Center, Chicago, USA

PDF源文件 DOI 网页
88 天

Potential clinical relevance of rare dihydropyrimidine dehydrogenase genetic variants identified using whole-exome NextGen sequencing in cancer patients with severe fluoropyrimidine toxicity

作者Elizabeth Cui; Samantha Medwid; Ute I. Schwarz; Richard B. Kim

作者单位1. Department of Physiology and Pharmacology, Western University, London, Canada; 2. Department of Medicine, Western University, London, Canada; 3. London Health Sciences Centre Research Institute, London, Canada

PDF源文件 DOI 网页
102 天

Selection of isatuximab dosing regimen in pediatric patients with leukemia using population pharmacokinetics

作者Claire Brillac; Dorothée Sémiond; Corina Oprea; André Baruchel; C. Michel Zwaan; Laurent Nguyen

作者单位1. Sanofi Research and Development, Vitry-sur-Seine, France; 2. Sanofi, Cambridge, MA, USA; 3. Robert Debré University Hospital (APHP and Université Paris Cité), Paris, France; 4. Princess Máxima Centre for Pediatric Oncology, Utrecht, The Netherlands, and Department of Pediatric Oncology, Erasmus MC - Sophia Children’s Hospital, Rotterdam, The Netherlands

PDF源文件 DOI 网页
107 天

Mechanisms of resistance to antibody-drug conjugates in cancer: molecular barriers and pharmacological solutions

作者Lina Eltaib; Muhammad Afzal; Chandana Maji; H. Malathi; Kavita Goyal; Haider Ali; Gaurav Gupta; Md Sadique Hussain

作者单位1. Department of Pharmaceutics, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia; 2. Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College, Jeddah, Saudi Arabia; 3. Noida Institute of Engineering and Technology (Pharmacy Institute), Greater, India; 4. Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, India; 5. Department of Biotechnology, Graphic Era (Deemed to be University), Clement Town, Dehradun, India; 6. Centre for Global Health Research, Saveetha Institute of Medical and Technical Sciences, Saveetha Medical College, Saveetha University, Chennai, India; 7. Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Rajpura, India; 8. Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, UAE; 9. Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India; 10. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India

PDF源文件 DOI 网页
132 天

Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer

作者Martina Catalano; Gestiana Cekrezi; Irene De Gennaro Aquino; Delia Ravizza; Alexandra Paulet; Kristian Shtembari; Claudia De Angelis; Roberto Petrioli; Daniele Generali; Giandomenico Roviello

作者单位1. Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy; 2. School of Medicine and Surgery, University of Florence, Florence, Italy; 3. Clinical Oncology, Careggi University Hospital, Florence, Italy; 4. Medical Oncology Unit, Careggi University Hospital, Florence, Italy; 5. Unit of Medical Oncology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy; 6. Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy; 7. Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Cremona, Italy

PDF源文件 DOI 网页
152 天

6-gingerol alleviates chemotherapy-induced nausea and vomiting by inhibiting ferroptosis via the regulation of iron homeostasis

作者Wan Liang; Lei Feng; Siyu Han; Chenglu Yang; Binbin Ye; Ziyao Mo; Ke Nie

作者单位1. School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, P.R. China

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。